In a major development, the National Institute of Virology (NIV) situated in Pune, Maharashtra has achieved success in developing the nation's first indigenous COVID-19 antibody test kit, reports Financial Express.
The positive development was made public by Union Minister of Health and Family Welfare Dr Harsh Vardhan. He also highlighted that the test kit developed by NIV, Pune boasts of the advantage to test 90 samples in a single run of 2.5 hours.
The test kit's performance was validated at two sites in Mumbai and has been found to have high sensitivity and accuracy. Furthermore, the technology has been transferred to Indian pharmaceutical giant Zydus Cadila to ensure mass production of the same. The Drug Controller General has granted commercial production and marketing permission to the company.
The development gains much significance as it comes in the backdrop of the Indian Council of Medical Research (ICMR) having cancelled orders for over half a million rapid antibody test kits from China after those were found to be delivering inaccurate results.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.